Badamo v. Chevron U.S.A. Inc.

CourtDistrict Court, S.D. New York
DecidedMay 9, 2022
Docket1:20-cv-05847
StatusUnknown

This text of Badamo v. Chevron U.S.A. Inc. (Badamo v. Chevron U.S.A. Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Badamo v. Chevron U.S.A. Inc., (S.D.N.Y. 2022).

Opinion

USDC SDNY DOCUMENT UNITED STATES DISTRICT COURT ELECTRONICALLY FILED SOUTHERN DISTRICT OF NEW YORK DOC #: Sonnac anne KK DATE FILED:_05/09/2022 SEBASTIAN P. BADAMO, Executor for the Estate of — : Carlo G. Badamo, Deceased, : Plaintiff, : 20-cv-5847 (LJL) -v- : OPINION AND ORDER CHEVRON U.S.A. INC., F/K/A GULF OIL : CORPORATION, et al, : Defendants. :

we KX LEWIS J. LIMAN, United States District Judge: Plaintiff Sebastian P. Badamo (“Plaintiff”), Executor for the Estate of Carlo G. Badamo (“Badamo”), brings a claim under the Jones Act, 46 U.S.C. § 30104, alleging that Badamo suffered from asbestos-related cancer due to the negligence of defendants Chevron U.S.A. Inc. F/K/A Gulf Oil Corporation (“Chevron”); Chiquita Brands International, Inc. as successor in interest to United Fruit Company (“Chiquita”); Farrell Lines, Inc. F/K/A American South African Lines, individually and as successor in interest to America Export Lines, Inc. (‘Farrell Lines”); and National Bulk Carriers, Inc. (“National Bulk Carriers”). Dkt. No. 50. Farrell Lines, Chiquita, and Chevron (collectively “Defendants”) each move for summary judgment. Dkt. Nos. 80, 92, 96. For the following reasons, the motions for summary judgment are denied.

BACKGROUND The following facts are undisputed for purposes of these motions except where otherwise indicated.1 I. Facts Regarding the Statute of Limitations In 2008, Badamo filed a lawsuit against multiple shipowner employers, shipbuilders, machinery manufacturers, and distributors, alleging that he suffered from various injuries and

diseases due to asbestos exposure aboard vessels during his merchant marine career. Dkt. No. 81 (“Def.’s 56.1”) ¶ 9; Dkt. No. 88 (“Pl.’s CS”) ¶ 9; Dkt. No. 83-3.2 On July 17, 2017, Badamo underwent a chest X-ray, which showed: “Ill-defined large masslike opacities seen projected over the left lower lobe, new from prior exams. Findings may represent a large pleural plaque. However, further assessment with dedicated CT scan of the chest with contrast is recommended for clarification of findings and exclusion of a mass.” Def.’s 56.1 ¶ 2; Pl.’s CS ¶ 2; see also Dkt. No. 83-1 at 2.

1 Defendants Farrell Lines, Chiquita, and Chevron submitted Rule 56.1 statements with almost identical facts. See Dkt. No. 81 ¶¶ 1–9; Dkt. No. 95 ¶¶ 1–9; Dkt. No. 98 ¶¶ 1–9. Chevron’s 56.1 statement also included additional facts related to its non-statute-of-limitations asbestos-exposure argument. See Dkt. No. 98 ¶¶ 10–24. Plaintiff’s counter statements to the three 56.1 statements included almost identical responses and additional facts. See Dkt. No. 88 ¶¶ 1–18; Dkt. No. 104 ¶¶ 1–18; Dkt. No. 101 ¶¶ 1–9, 25–33. Farrell Lines and Chevron submitted reply 56.1 statements. See Dkt. Nos. 90, 106. For ease of reference, when referring to the common facts among the three 56.1 statements, this Opinion cites to Farrell Lines’ 56.1 statement, Plaintiff’s counter statement to Farrell Lines’ 56.1 statement, Farrell Lines’ reply statement, and the related docket entries. See Dkt. Nos. 81, 88, 90. 2 The 2008 complaint alleged that: “As a direct and proximate result of said exposure to asbestos, Plaintiff suffers cancerphobia, traumatic stressful fear of affliction and worsening of pneumoconiosis as well as exacerbation of existing diseases; and suffers anatomical disorder, structural changes, pulmonary diseases inclusive of asbestosis / mesothelioma / lung cancer / pneumoconiosis / chronic obstructive pulmonary disease / colon cancer / stomach cancer / rectal cancer / kidney cancer / pancreas cancer / pharynx cancer / brain cancer / other anatomical cancer, et cetera, either singularly or in combination thereof; and, moreover, Plaintiff suffers harm in the form of necessity to be monitored for other asbestotic diseases including lung cancer.” Dkt. No. 83-3 ¶ 11. On July 21, 2017, Badamo underwent a CT scan of his chest, which showed a seven- centimeter mass in the left lower lobe of the lung that was “highly suspicious for primary lung neoplasm.” Def.’s 56.1 ¶ 3; Pl.’s CS ¶ 3; Dkt. No. 83-1 at 5. The CT scan report stated that “[i]nterventional radiology consultation for image guided biopsy of the dominant mass for a definitive tissue diagnosis is recommended.” Dkt. No. 83-1 at 5–6.

On July 26, 2017, Badamo met with Madhu S. Gowda, M.D. (“Dr. Gowda”) who Plaintiff identifies as Badamo’s primary care physician. Def.’s 56.1 ¶ 4; Pl.’s CS ¶ 4. The assessment and plan section of the visit record noted a “[l]arge lung mass in the left lower lobe with multiple small lung nodules in the same lung highly suggestive of advanced lung cancer and a high risk patient with previous history of more than 40-pack-year smoking history and asbestos exposure with pleural [p]laque.” Def.’s 56.1 ¶ 4; Pl.’s CS ¶ 4; Dkt. No. 83-1 at 14. The record also stated, “we will arrange for a CT-guided biopsy,” “[w]e will get a PET scan,” and “[w]e will get oncology consult,” among other things. Dkt. No. 83-1 at 14. The record also noted that “[p]atient and his family [were] extensively counseled.” Id. The end of the record stated that the

“Plan and Recommendations [were] discussed with the patient in detail” and that “Patient’s questions were discussed and answered.” Id. at 16. On August 1, 2017, Badamo underwent a PET scan, and the impressions from the scan stated in part: “Intense activity in a large left lower lobe lung lesion . . . , suspicious for malignancy. Nodular change inferior to this more posterior and inferior within the left lower lobe also showing uptake and I suspect local metastatic disease versus adjacent inflammatory change. More equivocal are the nodular areas in the lingula, one shows mild uptake. Differential would include inflammatory change.” Pl.’s CS ¶ 13; Dkt. No. 90 (“Def.’s 56.1 Reply”) ¶ 13; Dkt. No. 89-1 at 29. David M. Rosenberg, M.D. (“Dr. Rosenberg”), an expert for Defendants, agreed with Plaintiff’s counsel that “there was no way that Carlo Badamo could have learned that he had lung cancer unless and until he went to a hospital and had a biopsy done.” Pl.’s CS ¶ 16; Def.’s 56.1 Reply ¶ 16; Dkt. No. 89-7 at 45:5–9. Dr. Rosenberg also agreed with Plaintiff’s counsel that as of “July 26th and July 27th, no doctor should be telling Mr. Badamo that in fact he has lung

cancer without getting the pathology reports back.” Pl.’s CS ¶ 15; Def.’s 56.1 Reply ¶ 15; Dkt. No. 89-7 at 50:19–24. On August 2, 2017, a biopsy of the mass on the lower lobe of the left lung was performed, and the diagnosis was stated to be “adenocarcinoma, with features compatible with lung primary.” Def.’s 56.1 ¶ 7; Pl.’s CS ¶ 7; Dkt. No. 83-1 at 17. On August 9, 2017, Badamo saw Dr. Gowda again for follow-up. Pl.’s CS ¶ 14; Def.’s 56.1 Reply ¶ 14; Dkt. No. 89-1 at 33. Compared to the record from the July 26, 2017 visit, the record from this visit reflects that the diagnosis of “Malignant neoplasm of the left lung/adenoca” was added to the “Patient Active Problem List.” Pl.’s CS ¶ 14; Def.’s 56.1 Reply ¶ 14; Dkt. No.

89-1 at 33. The instant lawsuit was filed on July 28, 2020. Def.’s 56.1 ¶ 1; Pl.’s CS ¶ 1; see also Dkt. No. 1. Badamo passed away on November 15, 2020. Def.’s 56.1 ¶ 8; Pl.’s CS ¶ 8. II. Badamo and the Chevron Vessels—the Gulf Maracaibo, Gulfhorn, Gulfmills, and Gulfswamp Badamo served in the merchant marines for eleven years from 1944 to 1955. Dkt. No. 98 (“Chevron 56.1”) ¶ 11; Dkt. No. 101 (“Pl.’s CS Chevron”) ¶ 11. During his eleven years in the merchant marines, Badamo served on various vessels, including four of Chevron’s ships—the Gulf Maracaibo, Gulfhorn, Gulfmills, and Gulfswamp. Chevron 56.1 ¶ 12; Pl.’s CS Chevron ¶ 12.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Urie v. Thompson
337 U.S. 163 (Supreme Court, 1949)
Rogers v. Missouri Pacific Railroad
352 U.S. 500 (Supreme Court, 1957)
Ferguson v. Moore-McCormack Lines, Inc.
352 U.S. 521 (Supreme Court, 1957)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Norfolk & Western Railway Co. v. Ayers
538 U.S. 135 (Supreme Court, 2003)
William F. Bradt, Libelant-Appellee v. United States
221 F.2d 325 (Second Circuit, 1955)
Kurt A. Puthe v. Exxon Shipping Co.
2 F.3d 480 (Second Circuit, 1993)
Scotto v. Almenas
143 F.3d 105 (Second Circuit, 1998)
Laura Holtz v. Rockefeller & Co., Inc.
258 F.3d 62 (Second Circuit, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
Badamo v. Chevron U.S.A. Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/badamo-v-chevron-usa-inc-nysd-2022.